Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Kursexplosion von 383 % seit November und massiver Solana-Outperformer!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
179 Leser
Artikel bewerten:
(1)

BCC Research LLC: Nutraceuticals Market Set for 6.4% CAGR Growth to $571.3 Billion

Finanznachrichten News

"Nutraceuticals are products like supplements, functional foods, and drinks that provide health benefits beyond basic nutrition, such as boosting wellness or managing health conditions. BCC Research Study Highlights Market Growth from $418.2 Billion in 2024 to $571.3 Billion by 2029"

BOSTON, Jan. 21, 2025 /PRNewswire/ -- According to the latest study from BCC Research, the demand for Nutraceuticals: Global Markets is expected to grow from $418.2 billion in 2024 to $571.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2024 to 2029.

BCC Research Logo

The report forecasts the nutraceuticals market from 2024 to 2029, covering major companies and market segments such as functional beverages, foods, and supplements. Applications include wellness, weight management, heart, and digestive health. The report also analyzes distribution channels such as e-commerce, supermarkets, and pharmacies, as well as regional markets of North America, Europe, Asia-Pacific, and Rest of the World.

Interesting facts

The rise of e-commerce and retail chains is driving the growth of processed food, making nutraceuticals more accessible and increasing their demand.

Factors contributing to the market's growth include:

  1. Growing Prevalence of Overweight and Obesity: The growing number of overweight and obese people is caused by unhealthy diets, lack of exercise, and poor lifestyle choices. This can lead to heart problems, diabetes and other diseases.
  2. Increasing Demand for Dietary Supplements: More people are turning to vitamins, minerals, and herbal supplements to improve their health, increase energy, and address nutritional gaps, driven by greater health awareness and busy lifestyles.
  3. Increasing Healthcare Costs: Medical services, treatments, and insurance are becoming more expensive due to the world's aging populations, meaning more people with chronic diseases.

Request a Sample Copy of the Nutraceuticals: Global Markets

Report Synopsis

Report Metric

Details

Base year considered

2023

Forecast period considered

2024-2029

Base year market size

$399.0 billion

Market size forecast

$571.3 billion

Growth rate

CAGR of 6.4% for the forecast period of 2024-2029

Segments covered

Product Type, Application, Distribution Channel, and Region

Regions covered

North America, Europe, Asia-Pacific, and Rest of the World

Countries covered

U.S., Canada, Mexico, Germany, France, U.K., Spain, Italy, China, India, Japan, Brazil, South Africa, and UAE

Market drivers

•Growing Prevalence of Overweight and Obesity.
•Increasing Demand for Dietary Supplements.
•Increasing Healthcare Costs

This report addresses the following questions:

  1. What is the projected growth rate and size of the nutraceuticals market?
    The estimated size of the nutraceuticals market will be $ 571.3 billion by the end of 2029, with a CAGR of 6.4%.
  2. What factors are driving the growth of the nutraceuticals market?
    The growing prevalence of overweight and obesity, increasing demand for dietary supplements and increasing healthcare costs.
  3. Which product type will dominate the market in 2029?
    The functional beverages segment will continue to dominate the market through 2029.
  4. Which region has the largest market share?

North America holds the largest market share, driven by the growing demand for health and wellness products and its well-established nutraceutical industry.

Leading companies in the market include:

  • Abbott
  • Ajinomoto Co. Inc.
  • Beneo
  • Cargill Inc.
  • Danone S.A.
  • DSM-Firmenich
  • Herbalife International of America Inc.
  • Hildur Functional Foods Pvt. Ltd.
  • International Flavors & Fragrances Inc.
  • Nestle
  • Novozymes A/S

Related reports include:

Commercial Amino Acids: Commercial amino acids are amino acids made in large quantities for use in food, medicine, and animal feed. They are produced through fermentation or chemical methods and are used for health, nutrition, or functional purposes. Examples include glutamine, lysine, and threonine.

Purchase a copy of the report direct from BCC Research.

For further information on these reports or to purchase one, please contact info@bccresearch.com.

About BCC Research

BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts' goal is to help readers make informed business decisions, free of noise and hype.

Contact Us

Corporate HQ: 50 Milk St. Ste 16, Boston, MA 02109, USA
Email: info@bccresearch.com,
Phone: +1 781-489-7301
For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library.

Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.

Logo: https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/nutraceuticals-market-set-for-6-4-cagr-growth-to-571-3-billion-302356466.html

© 2025 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.